Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | CTLT |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Catalent Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 128.01 | 183.09 | 14.83 | 360.22 | 61.20 |
| High | 129.68 | 184.22 | 14.93 | 364.45 | 61.20 |
| Low | 123.84 | 180.98 | 14.80 | 359.29 | 60.63 |
| Last | 127.06 | 183.49 | 14.89 | 363.55 | 60.96 |
| Change | -1.37 | +0.60 | -0.06 | +3.33 | +0.01 |
| % Change | -1.07% | +0.33% | -0.40% | +0.92% | +0.02% |
| Volume | 1,236,800 | 2,328,500 | 1,859,500 | 464,800 | 2,038,400 |
| 20-Day Average Volume | 963,285 | 1,791,405 | 2,143,500 | 478,595 | 1,533,280 |
| Previous Close | 128.43 | 182.89 | 14.95 | 360.22 | 60.95 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 145.36 | 183.44 | 14.44 | 338.90 | 59.66 |
| 20-Day Raw Stochastic | 20.79% | 62.57% | 89.39% | 95.24% | 90.73% |
| 20-Day Relative Strength | 35.89% | 53.89% | 64.32% | 67.78% | 72.35% |
| Weighted Alpha | +5.72 | -0.79 | +2.06 | +75.06 | +28.74 |
| Today's Opinion | 8% Buy | 88% Buy | 64% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 8% Buy | 72% Buy | 56% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 8% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.85% since 08/23/24 | +1.43% since 08/23/24 | -1.26% since 08/23/24 | +4.46% since 08/23/24 | +2.56% since 08/23/24 |
| Low | 119.76 on 08/28/24 | 180.52 on 08/26/24 | 14.79 on 08/26/24 | 343.13 on 08/27/24 | 59.18 on 08/26/24 |
| High | 154.00 on 08/26/24 | 184.71 on 08/29/24 | 15.06 on 08/28/24 | 365.98 on 08/28/24 | 61.20 on 08/30/24 |
| 1-Month | |||||
| %Chg | -10.00% since 07/30/24 | +0.91% since 07/30/24 | +9.08% since 07/30/24 | +7.71% since 07/30/24 | +3.25% since 07/30/24 |
| Low | 119.76 on 08/28/24 | 172.24 on 08/05/24 | 13.29 on 08/06/24 | 310.00 on 07/31/24 | 58.61 on 08/05/24 |
| High | 157.98 on 08/01/24 | 190.22 on 08/07/24 | 15.08 on 08/23/24 | 365.98 on 08/28/24 | 61.20 on 08/30/24 |
| 3-Month | |||||
| %Chg | -7.02% since 05/30/24 | +8.29% since 05/30/24 | +14.27% since 05/30/24 | +34.42% since 05/30/24 | +13.71% since 05/30/24 |
| Low | 119.76 on 08/28/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 268.65 on 05/31/24 | 53.62 on 05/31/24 |
| High | 157.98 on 08/01/24 | 190.22 on 08/07/24 | 15.08 on 08/23/24 | 365.98 on 08/28/24 | 61.20 on 08/30/24 |
| 6-Month | |||||
| %Chg | -2.56% since 02/29/24 | -7.48% since 02/29/24 | +2.06% since 02/29/24 | +61.12% since 02/29/24 | +6.31% since 02/29/24 |
| Low | 119.76 on 08/28/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 221.53 on 04/01/24 | 53.51 on 05/29/24 |
| High | 157.98 on 08/01/24 | 196.23 on 03/01/24 | 15.08 on 08/23/24 | 365.98 on 08/28/24 | 61.20 on 08/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,786,938 | 83,725,576 | 47,124,424 | 16,125,620 | 11,032,540 |
| Shares Outstanding, K | 100,637 | 456,295 | 3,164,837 | 44,356 | 180,980 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 4,263,000,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | -256,000,000 |
| Last Quarter Sales | 590,200,000 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 1,074,000,000 |
| Last Quarter Net Income | 65,000,000 | 624,000,000 | 609,590,000 | 278,100,000 | -101,000,000 |
| 60-Month Beta | 0.37 | 0.86 | 0.54 | 0.55 | 1.16 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.63 on 08/01/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.65 on 08/29/24 |
| Latest Earnings Date | 08/01/24 | 08/06/24 | 10/24/24 | 07/31/24 | 09/03/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 38.80 | 33.01 | 9.52 | 16.55 | 0.00 |